• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铜绿假单胞菌肺部定植后囊性纤维化患者的肺功能和临床病程

Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa.

作者信息

Kerem E, Corey M, Gold R, Levison H

机构信息

Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.

出版信息

J Pediatr. 1990 May;116(5):714-9. doi: 10.1016/s0022-3476(05)82653-8.

DOI:10.1016/s0022-3476(05)82653-8
PMID:2109790
Abstract

To evaluate the relationship between Pseudomonas aeruginosa colonization and the development of lung disease, we studied 895 patients who attended our cystic fibrosis clinic between 1975 and 1988. The prevalence of P. aeruginosa colonization was 82%. Patients who acquired P. aeruginosa in the first year of life had a similar 10-year survival rate (85%) to that in patients who were colonized between the ages of 1 and 7 years (87%), and to that in patients colonized after the age of 7 years (78%). One year before colonization, mean age, forced expiratory volume in 1 second (FEV1), forced vital capacity, and forced expiratory flow in the mid-expiratory phase were similar to those in a group of patients who remained free of P. aeruginosa. No significant change in pulmonary function variables could be demonstrated 1 year and 2 years after the colonization. The rate and duration of hospitalization did not increase in the years after P. aeruginosa colonization compared with the years before colonization. By the age of 7 years, the mean percentage of predicted FEV1 was lower by 10% in patients who were already colonized by P. aeruginosa compared with those who were not colonized (p less than 0.01). A similar reduction in FEV1 was observed at all ages from 7 to 35 years, but no precipitate rate of decline in FEV1 could be associated with P. aeruginosa colonization. We conclude that although P. aeruginosa colonization is associated with 10% lower lung function, it does not cause an immediate and rapid reduction, as has been previously reported. The clinical course and the pulmonary deterioration in cystic fibrosis after P. aeruginosa colonization is a gradual and variable process.

摘要

为了评估铜绿假单胞菌定植与肺部疾病发展之间的关系,我们研究了1975年至1988年间在我们囊性纤维化诊所就诊的895例患者。铜绿假单胞菌定植的患病率为82%。1岁时感染铜绿假单胞菌的患者10年生存率(85%)与1至7岁定植患者(87%)以及7岁后定植患者(78%)相似。在定植前一年,平均年龄、第一秒用力呼气量(FEV1)、用力肺活量和呼气中期用力呼气流量与一组未感染铜绿假单胞菌的患者相似。定植后1年和2年,肺功能变量无明显变化。与定植前几年相比,铜绿假单胞菌定植后几年的住院率和住院时间没有增加。到7岁时,已感染铜绿假单胞菌的患者预计FEV1的平均百分比比未感染患者低10%(p<0.01)。在7至35岁的所有年龄段都观察到FEV1有类似程度的下降,但FEV1的下降速度与铜绿假单胞菌定植无关。我们得出结论,虽然铜绿假单胞菌定植与肺功能降低10%有关,但它不会像先前报道的那样导致立即和快速的下降。铜绿假单胞菌定植后囊性纤维化的临床病程和肺部恶化是一个渐进且多变的过程。

相似文献

1
Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa.铜绿假单胞菌肺部定植后囊性纤维化患者的肺功能和临床病程
J Pediatr. 1990 May;116(5):714-9. doi: 10.1016/s0022-3476(05)82653-8.
2
Respiratory tract colonization with Pseudomonas aeruginosa in cystic fibrosis: correlations between anti-Pseudomonas aeruginosa antibody levels and pulmonary function.
Pediatr Pulmonol. 1991;10(2):92-100. doi: 10.1002/ppul.1950100210.
3
Effects of pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis.铜绿假单胞菌定植对囊性纤维化患儿肺功能及人体测量学变量的影响。
Pediatr Pulmonol. 1995 Jan;19(1):10-5. doi: 10.1002/ppul.1950190103.
4
Pulmonary evolution of cystic fibrosis patients colonized by Pseudomonas aeruginosa and/or Burkholderia cepacia.铜绿假单胞菌和/或洋葱伯克霍尔德菌定植的囊性纤维化患者的肺部病变进展
Eur J Pediatr. 1998 May;157(5):427-31. doi: 10.1007/s004310050844.
5
Clinical and microbiological characteristics of cystic fibrosis adults never colonized by Pseudomonas aeruginosa: Analysis of the French CF registry.囊性纤维化成人从未被铜绿假单胞菌定植的临床和微生物学特征:法国 CF 登记处的分析。
PLoS One. 2019 Jan 8;14(1):e0210201. doi: 10.1371/journal.pone.0210201. eCollection 2019.
6
Risk factors for Pseudomonas aeruginosa colonization in cystic fibrosis patients.
Pediatr Infect Dis J. 1990 Jul;9(7):494-8. doi: 10.1097/00006454-199007000-00008.
7
Clinical impact of Pseudomonas aeruginosa colonization in patients with Primary Ciliary Dyskinesia.原发性纤毛运动障碍患者铜绿假单胞菌定植的临床影响。
Respir Med. 2017 Oct;131:241-246. doi: 10.1016/j.rmed.2017.08.028. Epub 2017 Sep 1.
8
Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function.囊性纤维化儿科患者的阿奇霉素维持治疗:与大环内酯类耐药性和肺功能相关的长期结局
Pediatr Infect Dis J. 2007 Jan;26(1):8-12. doi: 10.1097/01.inf.0000247109.44249.ac.
9
The prevalence of cutaneous hypersensitivity and its relationship to Pseudomonas colonization and outcome in cystic fibrosis.
Clin Exp Allergy. 1990 Jul;20(4):415-9. doi: 10.1111/j.1365-2222.1990.tb02803.x.
10
Progression of pulmonary disease after disappearance of Pseudomonas in cystic fibrosis.
Am J Respir Crit Care Med. 1995 Jul;152(1):169-73. doi: 10.1164/ajrccm.152.1.7599818.

引用本文的文献

1
The impact of probiotics on pulmonary, gastrointestinal, and growth outcomes in pediatric cystic fibrosis: a randomized controlled trial.益生菌对小儿囊性纤维化患者肺部、胃肠道及生长结局的影响:一项随机对照试验。
BMC Pediatr. 2025 May 28;25(1):430. doi: 10.1186/s12887-025-05789-0.
2
Therapeutic Interventions for Infections in Cystic Fibrosis Patients: A Review of Phase IV Trials.囊性纤维化患者感染的治疗干预措施:IV期试验综述
J Clin Med. 2024 Oct 30;13(21):6530. doi: 10.3390/jcm13216530.
3
Pseudomonas aeruginosa senses and responds to epithelial potassium flux via Kdp operon to promote biofilm.
铜绿假单胞菌通过 Kdp 操纵子感知和响应上皮细胞钾离子流,以促进生物膜的形成。
PLoS Pathog. 2024 May 31;20(5):e1011453. doi: 10.1371/journal.ppat.1011453. eCollection 2024 May.
4
Impact of CFTR Modulation on Pseudomonas aeruginosa Infection in People With Cystic Fibrosis.囊性纤维化患者中 CFTR 调节对铜绿假单胞菌感染的影响。
J Infect Dis. 2024 Sep 23;230(3):e536-e547. doi: 10.1093/infdis/jiae051.
5
Current cough and sputum assessed by the cough and sputum assessment-questionnaire (CASA-Q) is associated with quality of life impairment in cystic fibrosis.目前,通过咳嗽和咳痰评估问卷(CASA-Q)评估的咳嗽和咳痰与囊性纤维化患者的生活质量受损有关。
BMC Pulm Med. 2023 Nov 21;23(1):457. doi: 10.1186/s12890-023-02701-3.
6
High prevalence of lipopolysaccharide mutants and R2-Pyocin susceptible variants in populations sourced from cystic fibrosis lung infections.源自囊性纤维化肺部感染的人群中脂多糖突变体和R2-绿脓菌素敏感变体的高流行率。
bioRxiv. 2023 Sep 6:2023.04.26.538445. doi: 10.1101/2023.04.26.538445.
7
Furin as a therapeutic target in cystic fibrosis airways disease.丝氨酸蛋白酶 furin 作为囊性纤维化气道疾病的治疗靶点。
Eur Respir Rev. 2023 May 3;32(168). doi: 10.1183/16000617.0256-2022. Print 2023 Jun 30.
8
Gaps in Cystic Fibrosis Care Are Associated with Reduced Lung Function in the U.S. Cystic Fibrosis Foundation Patient Registry.美国囊性纤维化基金会患者注册中心的研究表明,囊性纤维化护理中的差距与肺功能下降有关。
Ann Am Thorac Soc. 2023 Sep;20(9):1250-1257. doi: 10.1513/AnnalsATS.202211-951OC.
9
Therapeutic beta-lactam dosages and broad-spectrum antibiotics are associated with reductions in microbial richness and diversity in persons with cystic fibrosis.治疗用β-内酰胺类药物和广谱抗生素与囊性纤维化患者微生物丰富度和多样性的减少有关。
Sci Rep. 2023 Jan 21;13(1):1217. doi: 10.1038/s41598-023-27628-x.
10
Killing three birds with one BPI: Bactericidal, opsonic, and anti-inflammatory functions.用一种杀菌/渗透增强蛋白达成三重功效:杀菌、调理素化及抗炎功能。
J Transl Autoimmun. 2021 May 28;4:100105. doi: 10.1016/j.jtauto.2021.100105. eCollection 2021.